Protocol B7791001 Statistical Analysis Plan PFIZER CONFIDENTIAL Page 1Protocol B7791001 A PHASE 1 STUDY TO E VALUATE THE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ESCALATING DOSES OF A VACCINE -BASED IMMUNOTHERAPY REGIME N (VBIR) FOR PROSTAT E CANCER (PF -06753512) Statistical Analysis Plan (SAP) Version :Amendment 2 Date: 08-JUN-2020 Protocol B7791001 Statistical Analysis Plan PFIZER CONFIDENTIAL Page 2TABLE OF CONTENTS LIST OF TABLES................................................................................................................. ....3 LIST OF FIGURES ................................................................................................................